Jemma Weymouth

Vice President

As a vice president at Burness, Jemma Weymouth brings expertise in strategic communication, media relations, training and writing to projects with foundations including the Robert Wood Johnson Foundation; nonprofits and research institutes, such as the Health Care Cost Institute and the Institute for Clinical and Economic Review; and government agencies, including the Agency for Healthcare Research and Quality, Centers for Disease Control, and The Presidential Commission for the Study of Bioethical Issues.

Prior to joining Burness, Jemma was a senior associate at Metropolitan Group, working with non-profit organizations, foundations and public agencies on a wide range of issues, including health, education, immigration, and community and economic development. Clients she worked with include W.K. Kellogg Foundation, the YMCA of the USA, and the National Council of La Raza. Jemma has also worked for the Capital Area Food Bank, assisting with marketing, public relations and special events. Before moving to Washington, D.C., Jemma provided communications, public relations and marketing services to consumer and corporate projects in the U.K., which included promoting smart growth real estate development and retail destinations.

Jemma earned her bachelor’s degree in media, culture and society from the University of Birmingham, England. When she’s not in the office, Jemma is hiking, biking and generally enjoying the great outdoors.

Posts By Jemma

Making Data Useful

The Healthy Marketplace Index helps people compare health care costs in their communities to others.

Are High Drug Prices Here to Stay?

Last week the FDA approved PCSK9 inhibitors, which promise to help millions of Americans with high cholesterol. But these new drugs come with a projected price tag of about $14,600 a year. The PCSK9 inhibitors are the latest in a series of high-priced prescription drugs reaching the market.

Protecting Privacy in Whole Genome Sequencing

Whole genome sequencing—which provides a map of a person’s entire genetic makeup—has huge potential for improving medical care. Yet, concerns about personal privacy and misuse of data from these tests could deter people from getting their genes sequenced and sharing their genetic information with researchers and clinicians. That’s why the Presidential Commission for the Study of Bioethical Issues has undertaken a review of the privacy and data access issues that arise from whole genome sequencing.

All Posts by Jemma

Favorite Book

The BFG

If I Were a Breakfast Cereal, I'd Be

Toast